Sarepta Therapeutics announces pricing of $500,000,000 public offering of common stock
Sarepta Therapeutics announced it has priced an underwritten public offering of an aggregate of 3,817,000 shares of its common stock at a price to the public of $131.00 per share. In addition, Sarepta granted underwriters a 30-day option to purchase up to an additional 572,550 shares. November 08, 2018